These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10459925)

  • 1. Tuberculosis, Russia, and the Holy Grail.
    Banatvala N; Peremitin GG
    Lancet; 1999 Mar; 353(9157):999-1000. PubMed ID: 10459925
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance and tuberculosis elimination in low-incidence countries.
    Falzon D; Zellweger JP; Migliori GB; Jaramillo E
    Eur Respir J; 2014 Dec; 44(6):1408-11. PubMed ID: 25435527
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of multidrug-resistant tuberculosis in Russian prisons.
    Lafontaine D; Slavuski A; Vezhnina N; Sheyanenko O
    Lancet; 2004 Jan; 363(9404):246-7. PubMed ID: 14738811
    [No Abstract]   [Full Text] [Related]  

  • 4. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 5. NIAID describes research priorities for fighting drug-resistant tuberculosis.
    Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of tuberculosis in India.
    Mohapatra PR
    Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia.
    Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N
    Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stop TB Partnership has provided treatments for 10 million people in 6 years.
    Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential components of a tuberculosis control program within Australia.
    National Tuberculosis Advisory Committee
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E397-400. PubMed ID: 25631607
    [No Abstract]   [Full Text] [Related]  

  • 10. Russia: Drug-resistant TB can be contained.
    Lessem E; Keshavjee S
    Nature; 2014 Feb; 506(7488):295. PubMed ID: 24553229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculosis in Somalia with consequences in Sweden].
    Winstrand A; Kulane A; von Schreeb J
    Lakartidningen; 2010 Dec; 107(51-52):3279-81. PubMed ID: 21294349
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
    Grishin MN; Svistov VV; Krivoshein IuS
    Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deal struck for Russians with tuberculosis.
    Banatvala N
    Lancet; 1999 Jul; 354(9172):56. PubMed ID: 10406377
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impact of active detection and treatment of patients with tuberculosis on fatal outcomes].
    Glumnaia TV
    Probl Tuberk Bolezn Legk; 2006; (7):22-7. PubMed ID: 16944709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic marking of polyresistant mycobacterium tuberculosis strains isolated in the north-west of Russia].
    Narvskaia OV; Mokrousov IV; Otten TF; Vishnevskiĭ BI
    Probl Tuberk; 1999; (3):39-41. PubMed ID: 10420767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-resistant tuberculosis: mechanisms and management.
    Hayward CM; Herrman JL; Griffin GE
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):494-500. PubMed ID: 8574491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.